Fig. 1: Overall structure of CV30 Fab in complex with SARS-CoV-2 RBD and kinetics of glCV30.
From: Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation
From: Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation